PIEKOS BRIAN (Chief Financial Officer) sold 6.4% of their position (1.49K shares) of KALVISTA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $39.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/26/2026ACC: 0001815308-26-000004
Officer· Chief Financial Officer
Since Feb 2026
-1.49K
Net shares
Net seller
$39.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
5K acquired · 6.49K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5K
Price / share
—
Trade value
—
% of position
27.5%
5/21/2026
18.15K→23.15K
Common Stock
Direct
Shares
−1.49K
Price / share
$26.78
Trade value
$39.88K
% of position
6.4%
5/22/2026
23.15K→21.66K
Total
Net shares
+3.51K
Net value
-$39.88K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/21/2026 | M · Option Exercise | +5K | — | — | 27.5% | 18.15K | 23.15K |
| Common Stock Direct | 5/22/2026 | S · Sale | −1.49K | $26.78 | $39.88K | 6.4% | 23.15K | 21.66K |
| Total | +3.51K | -$39.88K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
5K shares
Shares
−5K
Strike price
Held after
55K
Exercisable
—
5/21/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock5K shares | 5/21/2026 | M · Option Exercise | −5K | — | 55K |